ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ANTX AN2 Therapeutics Inc

2.37
0.01 (0.42%)
2024年4月24日 - 終了
15分遅延
名称 銘柄コード 市場 種別
AN2 Therapeutics Inc ANTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01 0.42% 2.37 08:57:45
始値 安値 高値 終値 前日終値
2.36 2.31 2.42 2.37 2.36
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2905:10BWAN2 Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/2/1407:11EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1221:01EDGAR2Form 8-K - Current report
2024/2/1220:45BWAN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase..
2024/1/3106:10BWAN2 Therapeutics to Present at Oppenheimer Healthcare Life..
2024/1/1908:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1807:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1307:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1209:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0508:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0508:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0306:45EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0306:36EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1708:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1006:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:10EDGAR2Form 8-K - Current report
2023/11/1006:05BWAN2 Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0621:00BWAN2 Therapeutics to Present at Upcoming Investor Conferences
2023/10/1820:00BWAN2 Therapeutics Signs License Agreement with the University..
2023/10/1113:01BWAN2 Therapeutics to Present New Data for Epetraborole at..
2023/10/0408:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0305:10EDGAR2Form 144 - Report of proposed sale of securities
2023/9/3006:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/3005:11EDGAR2Form 144 - Report of proposed sale of securities
2023/9/2620:00BWAN2 Therapeutics Signs Grant Agreement to Discover Novel,..
2023/9/1606:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1321:00EDGAR2Form 8-K - Current report
2023/9/1320:00BWAN2 Therapeutics commences Phase 3 Part of Phase 2/3..
2023/9/0905:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2605:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2405:14EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1705:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/1705:47EDGAR2Form 8-K - Current report
2023/8/1611:42BWAN2 Therapeutics Announces Pricing of $70.0 Million..
2023/8/1105:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:18EDGAR2Form 8-K - Current report
2023/8/1105:10BWAN2 Therapeutics Reports Second Quarter 2023 Financial..
2023/5/2605:10BWAN2 Therapeutics to Present at Jefferies Healthcare..
2023/5/1205:10BWAN2 Therapeutics Reports First Quarter 2023 Financial..
2023/5/0120:00BWAN2 Therapeutics to Present at JMP Securities Life Sciences..

最近閲覧した銘柄

Delayed Upgrade Clock